Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial

被引：0
|
作者：
Emanuele Bosi
Carlo Bosi
Patrizia Rovere Querini
Nicasio Mancini
Giliola Calori
Annalisa Ruggeri
Cecilia Canzonieri
Luciano Callegaro
Massimo Clementi
Francesco De Cobelli
Massimo Filippi
Marco Bregni
机构：
[1] IRCCS Ospedale San Raffaele,Unit of Internal Medicine
[2] Vita-Salute San Raffaele University,Unit of Virology
[3] University of Milan Medical School,Clinical Trial Center
[4] IRCCS Ospedale San Raffaele,Unit of Radiology
[5] IRCCS Ospedale San Raffaele,Unit of Neurology
[6] IRCCS Ospedale San Raffaele,undefined
[7] IRCCS Ospedale San Raffaele,undefined
来源：
Trials | / 21卷
关键词：
IFNβ-1a; COVID-19; SARS-CoV-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial
    Vallejos, Julio
    Zoni, Rodrigo
    Bangher, Maria
    Villamandos, Silvina
    Bobadilla, Angelina
    Plano, Fabian
    Campias, Claudia
    Chaparro Campias, Evangelina
    Achinelli, Fernando
    Guglielmone, Hector A.
    Ojeda, Jorge
    Medina, Fernanda
    Farizano Salazar, Diego
    Andino, Gerardo
    Ruiz Diaz, Natalia E.
    Kawerin, Pablo
    Meza, Elba
    Dellamea, Silvana
    Aquino, Antonia
    Flores, Victor
    Martemucci, Carolina N.
    Vernengo, Maria Mercedes
    Martinez, Silvina Maria
    Segovia, Juan Emanuel
    Aguirre, Maria Gabriela
    [J]. TRIALS, 2020, 21 (01)
  • [42] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial
    Julio Vallejos
    Rodrigo Zoni
    Maria Bangher
    Silvina Villamandos
    Angelina Bobadilla
    Fabian Plano
    Claudia Campias
    Evangelina Chaparro Campias
    Fernando Achinelli
    Hector A. Guglielmone
    Jorge Ojeda
    Fernanda Medina
    Diego Farizano Salazar
    Gerardo Andino
    Natalia E. Ruiz Diaz
    Pablo Kawerin
    Elba Meza
    Silvana Dellamea
    Antonia Aquino
    Victor Flores
    Carolina N. Martemucci
    María Mercedes Vernengo
    Silvina María Martinez
    Juan Emanuel Segovia
    María Gabriela Aguirre
    [J]. Trials, 21
  • [43] Anti-interferon (IFN) antibodies in patients with relapsing remitting multiple sclerosis treated with recombinant IFNβ1a or IFNβ1b.
    Antonelli, G
    Simeoni, E
    Bagnato, F
    Pozzilli, C
    Currenti, M
    Di Marco, P
    Turriziani, O
    Riva, E
    Gasperini, C
    Dianzani, F
    Fieschi, C
    [J]. EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 337 - 337
  • [44] Interferon β-1a in ulcerative colitis:: a placebo controlled, randomised, dose escalating study
    Nikolaus, S
    Rutgeerts, P
    Fedorak, R
    Steinhart, AH
    Wild, GE
    Theuer, D
    Möhrle, J
    Schreiber, S
    [J]. GUT, 2003, 52 (09) : 1286 - 1290
  • [45] Neutralizing antibodies and efficacy of interferon β-1a -: A 4-year controlled study
    Kappos, L
    Clanet, M
    Sandberg-Wollheim, M
    Radue, EW
    Hartung, HP
    Hohlfeld, R
    Xu, J
    Bennett, D
    Sandrock, A
    Goelz, S
    [J]. NEUROLOGY, 2005, 65 (01) : 40 - 47
  • [46] Clinical characterisation of interferon inhibitory activity in multiple sclerosis patients treated with IFN-β-1a
    Weinstock-Guttman, B.
    Ramanathan, M.
    Zivadinov, R.
    Khan, A.
    Dillon, M.
    Patrick, K.
    Masud, M. W.
    Hojnacki, D.
    Chadha, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 501 - 502
  • [47] A preliminary metabolomic study of patients with multiple sclerosis treated with interferon β 1a
    Cocco, E.
    Lorefice, L.
    Murgia, F.
    Barberini, L.
    Frau, J.
    Fenu, G.
    Coghe, G.
    Melis, M.
    Murru, M. R.
    Murru, R.
    Poddighe, S.
    Atzori, L.
    Marrosu, M. G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 264 - 264
  • [48] Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
    Hassaniazad, Mehdi
    Bazram, Ali
    Hassanipour, Soheil
    Fathalipour, Mohammad
    [J]. TRIALS, 2020, 21 (01)
  • [49] Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial
    Rahimi, H.
    Allahyari, A.
    Ataei Azimi, S.
    Kamandi, M.
    Mozaheb, Z.
    Zemorshidi, F.
    Khadem-Rezaiyan, M.
    Bary, A.
    Seddigh-Shamsi, M.
    Nodeh, M. Moeini
    [J]. TRIALS, 2021, 22 (01)
  • [50] Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
    Mehdi Hassaniazad
    Ali Bazram
    Soheil Hassanipour
    Mohammad Fathalipour
    [J]. Trials, 21
12345